Paper3500928
The effect of 238Pu alpha-particles on the mouse fibroblast cell line C3H 10T1/2: characterization of source and RBE for cell survival.
Roberts CJ and 1 other. Int J Radiat Biol Relat Stud Phys Chem Med, 1987. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. The effect of 238Pu alpha-particles on the mouse fibroblast cell line C3H 10T1/2: characterization of source and RBE for cell survival. Papers, record 3500928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3500928
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of 238Pu alpha-particles on the mouse fibroblast cell line C3H 10T1/2: characterization of source and RBE for cell survival.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alpha Particles | Major topic |
| Cell Survival | Major topic |
| Plutonium | Major topic |
| Animals | |
| Cell Line | |
| Mice | |
| Radiation Dosage | |
| Relative Biological Effectiveness | |
| Time Factors |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39818312 | Inverse dose protraction effects of high-LET radiation: Evidence and significance. | Mutat Res Rev Mutat Res | 2025 | https://conductscience.org/library/papers/39818312 | PubMed |
| 20080889 | MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy. | J Nucl Med | 2010 | https://conductscience.org/library/papers/20080889 | PubMed |
| 9579824 | The promoting effect of tumour necrosis factor alpha in radiation-induced cell transformation. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9579824 | PubMed |
| 9400706 | A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny. | Environ Health Perspect | 1997 | https://conductscience.org/library/papers/9400706 | PubMed |
| 9108052 | Mutagenic effects of a single and an exact number of alpha particles in mammalian cells. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9108052 | PubMed |
| 2000445 | Criteria and techniques for analysing cell survival data. | Radiat Environ Biophys | 1991 | https://conductscience.org/library/papers/2000445 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3500928
GET https://conductscience.org/api/papers/v1/3500928/authors